Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans
Open accessThe DOI matches its Crossref record; 85 of the 86 references it cites were found in a registry or an index.
Abstract
Studies in animals have documented that, compared with glucose, dietary fructose induces dyslipidemia and insulin resistance. To assess the relative effects of these dietary sugars during sustained consumption in humans, overweight and obese subjects consumed glucose- or fructose-sweetened beverages providing 25% of energy requirements for 10 weeks. Although both groups exhibited similar weight gain during the intervention, visceral adipose volume was significantly increased only in subjects consuming fructose. Fasting plasma triglyceride concentrations increased by approximately 10% during 10 weeks of glucose consumption but not after fructose consumption. In contrast, hepatic de novo lipogenesis (DNL) and the 23-hour postprandial triglyceride AUC were increased specifically during fructose consumption. Similarly, markers of altered lipid metabolism and lipoprotein remodeling, including fasting apoB, LDL, small dense LDL, oxidized LDL, and postprandial concentrations of remnant-like particle-triglyceride and -cholesterol significantly increased during fructose but not glucose consumption. In addition, fasting plasma glucose and insulin levels increased and insulin sensitivity decreased in subjects consuming fructose but not in those consuming glucose. These data suggest that dietary fructose specifically increases DNL, promotes dyslipidemia, decreases insulin sensitivity, and increases visceral adiposity in overweight/obese adults.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Habitual consumption of significant amounts ( . 10% energy) of dietary fructose contributes to TG elevations, particularly in people with HTG.”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [158]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The impact of fructose/sucrose intake on HDL-C does not seem different from that of other refined carbohydrates.158,159”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [158]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Sucrose, a disaccharidecontaining glucose and fructose, represents an important source of fructose in the diet. 158,175”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [158]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Fructose has emerged as a potent activator of carbohydrate response element-binding protein (ChREBP), which is particularly relevant in the context of MASLD, given the global rise in fructose consumption that parallels the increasing prevalence of MASLD [78- 82].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [81]
Experimental — accuracy not yet measuredIn the citing paper
“dietary fructose contributes to TG elevations; these effects are dose dependent and become clinically relevant when the intake is .10%energy daily-with a habitual fructose consumption between 15 and 20% of the energy intake, plasma TG increases as much as 30 -40%.”
From ESC/EAS Guidelines for the management of dyslipidaemias (2011) · cites this paper as [76]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Follow-up report on the diagnosis of diabetes mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3160 · Cited by 3,784
A new predictive equation for resting energy expenditure in healthy individuals
Mifflin, M., St Jeor, S., Hill, L., Scott, B., Daugherty, S., & Koh, Y. (1990) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/51.2.241 · Cited by 2,544 · cited 1×
“calculated by the Mifflin equation (67), with an adjustment of 1.”
MethodNordestgaard, B. G., Benn, M., Schnohr, P., & Tybjærg-Hansen, A. (2007) · JAMA · doi:10.1001/jama.298.3.299 · Cited by 2,058
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women
Bansal, S., Buring, J. E., Rifai, N., Mora, S., Sacks, F. M., & Ridker, P. M. (2007) · JAMA · doi:10.1001/jama.298.3.309 · Cited by 1,619
Yu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200958200 · Cited by 1,561 · cited 1×
“Diacylglycerol is a known activator of novel PKC (51), and increases of both diacylglycerol and novel PKC activity are associated with lipid-induced insulin resistance (52, 53).”
BackgroundItani, S. I., Ruderman, N. B., Schmieder, F., & Boden, G. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2005 · Cited by 1,390
Lipoprotein lipase: structure, function, regulation, and role in disease
Mead, J., Irvine, S., & Ramji, D. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0384-9 · Cited by 927
Metabolic origins and clinical significance of LDL heterogeneity
Berneis, K. K., & Krauss, R. M. (2002) · Journal of Lipid Research · doi:10.1194/jlr.r200004-jlr200 · Cited by 896
Self-citationMorino, K., Petersen, K. F., & Shulman, G. I. (2006) · Diabetes · doi:10.2337/db06-s002 · Cited by 853 · cited 1×
“We propose that the increased hepatic lipid resulting from fructose-induced DNL leads to hepatic insulin resistance (49, 50), possibly by increasing levels of diacylglycerol (49).”
BackgroundConway, J. M., Ingwersen, L. A., Vinyard, B. T., & Moshfegh, A. J. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.5.1171 · Cited by 820
Research works printed but not linked: 1
- Schwarz, J.M., Neese, R.A., Schakleton, C., and Hellerstein, M.K. 1993. De novo lipogenesis during fasting and oral fructose ingestion in lean and obese hyperinsulinemic subjects [abstract]. Diabetes. 42 :A39.
Cited by
Items 401–500 of 1,008
Nutrition and Nonalcoholic Fatty Liver Disease
Chakravarthy, M. V., Waddell, T. K., Banerjee, R., & Guess, N. D. (2019) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2019.09.003 · Cited by 77
Pepe, R. B., Lottenberg, A. M., Fujiwara, C. T. H., Beyruti, M., Cintra, D. E., Machado, R. M., Rodrigues, A., Jensen, N. S. O., Caldas, A. P. S., Fernandes, A. E., et al. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01037-6 · Cited by 71
Altered Gut Microbiota: A Link Between Diet and the Metabolic Syndrome
Velasquez, M. T. (2018) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2017.0163 · Cited by 72
Fructose impairs fat oxidation: Implications for the mechanism of western diet-induced NAFLD
Inci, M. K., Park, S., Helsley, R. N., Attia, S. L., & Softic, S. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109224 · Cited by 69
Sottero, B., Gargiulo, S., Russo, I., Barale, C., Poli, G., & Cavalot, F. L. (2015) · Medicinal Research Reviews · doi:10.1002/med.21349 · Cited by 84
Retinoids ameliorate insulin resistance in a leptin-dependent manner in mice
Tsuchiya, H., Ikeda, Y., Ebata, Y., Kojima, C., Katsuma, R., Tsuruyama, T., Sakabe, T., Shomori, K., Komeda, N., Oshiro, S., et al. (2012) · Hepatology · doi:10.1002/hep.25798 · Cited by 68
Burmeister, M. A., Ayala, J., Drucker, D. J., & Ayala, J. E. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00446.2012 · Cited by 64
Guía de la ESC/EAS sobre el manejo de las dislipemias
Reiner, Ž., Catapano, A. L., Backer, G. D., Graham, I. M., Taskinen, M., Wiklund, O., Agewall, S., Alegría, E., Chapman, M. J., Durrington, P. N., et al. (2011) · Revista Española de Cardiología · doi:10.1016/j.recesp.2011.09.014 · Cited by 80
Yan, R., Chan, C. B., & Louie, J. C. Y. (2022) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac084 · Cited by 73
Obesity as malnutrition: the dimensions beyond energy balance
Wells, J. C. K. (2013) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.31 · Cited by 70
Fructose, uricase, and the Back‐to‐Africa hypothesis
Johnson, R. J., & Andrews, P. (2010) · Evolutionary Anthropology Issues News and Reviews · doi:10.1002/evan.20266 · Cited by 71
Wang, Y., Lara, J., Haskell‐Ramsay, C. F., & Lodge, J. K. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02299-w · Cited by 81
Mastrocola, R., Collino, M., Rogazzo, M., Medana, C., Nigro, D., Boccuzzi, G., & Aragno, M. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00450.2012 · Cited by 63
Lowndes, J., Sinnett, S., Yu, Z., & Rippe, J. (2014) · Nutrients · doi:10.3390/nu6083153 · Cited by 60
The fructose survival hypothesis for obesity
Johnson, R. J., Lanaspa, M. A., Sánchez‐Lozada, L. G., Tolan, D. R., Nakagawa, T., Ishimoto, T., Andrés-Hernando, A., Rodríguez‐Iturbe, B., & Stenvinkel, P. (2023) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2022.0230 · Cited by 73
The role of fructose in metabolism and cancer
Charrez, B., Qiao, L., & Hebbard, L. (2015) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2015-0009 · Cited by 67
Shen, D., Ye, H., Wang, Y., Ji, Y. S., Zhan, X., Zhu, J., & Li, W. (2013) · Surgical Endoscopy · doi:10.1007/s00464-013-2805-y · Cited by 63
Insulin Production and Resistance in Different Models of Diet-Induced Obesity and Metabolic Syndrome
Alwahsh, S. M., Dwyer, B. J., Forbes, S., Thiel, D. H. V., Lewis, P. J. S., & Ramadori, G. P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020285 · Cited by 69
Maki, K. C., Guyton, J. R., Orringer, C. E., Hamilton-Craig, I., Alexander, D. D., & Davidson, M. H. (2016) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2016.03.008 · Cited by 62
Prakash, P., Singh, V., Jain, M. K., Rana, M., Khanna, V., Barthwal, M. K., & Dikshit, M. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.01.038 · Cited by 65
Lyssiotis, C. A., & Cantley, L. C. (2013) · Nature · doi:10.1038/502181a · Cited by 73
FructationIn Vivo: Detrimental and Protective Effects of Fructose
Semchyshyn, H. M. (2013) · BioMed Research International · doi:10.1155/2013/343914 · Cited by 67
Hepatic oleate regulates adipose tissue lipogenesis and fatty acid oxidation
Burhans, M. S., Flowers, M. T., Harrington, K. R. V., Bond, L. M., Guo, C., Anderson, R. M., & Ntambi, J. M. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m054429 · Cited by 66
Effect of moderate intake of sweeteners on metabolic health in the rat
Figlewicz, D. P., Ioannou, G., Bennett Jay, J., Kittleson, S., Savard, C., & Roth, C. L. (2009) · Physiology & Behavior · doi:10.1016/j.physbeh.2009.09.016 · Cited by 62
Role of Nutrient-Sensing Signals in the Pathogenesis of Diabetic Nephropathy
Kume, S., Koya, D., Uzu, T., & Maegawa, H. (2014) · BioMed Research International · doi:10.1155/2014/315494 · Cited by 60
New Insights on the Risk for Cardiovascular Disease in African Americans: The Role of Added Sugars
Saab, K. R., Kendrick, J., Yracheta, J., Lanaspa, M. A., Pollard, M., & Johnson, R. J. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014040393 · Cited by 69
Sex Differences in Hepatic De Novo Lipogenesis with Acute Fructose Feeding
Low, W. S., Cornfield, T., Charlton, C. A., Tomlinson, J., & Hodson, L. (2018) · Nutrients · doi:10.3390/nu10091263 · Cited by 65
Treatment of Obesity in Mitigating Metabolic Risk
Heffron, S. P., Parham, J. S., Pendse, J., & Alemán, J. O. (2020) · Circulation Research · doi:10.1161/circresaha.119.315897 · Cited by 59
Added Fructose in Non-Alcoholic Fatty Liver Disease and in Metabolic Syndrome: A Narrative Review
Coronati, M., Baratta, F., Pastori, D., Ferro, D., Angelico, F., & Ben, M. D. (2022) · Nutrients · doi:10.3390/nu14061127 · Cited by 68
Olsen, N. J., Ängquist, L. H., Larsen, S. C., Linneberg, A. R., Skaaby, T., Husemoen, L. L. N., Toft, U., Tjønneland, A. M., Halkjær, J., Hansen, T. F., et al. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.122820 · Cited by 63
High fructose-induced metabolic changes enhance inflammation in human dendritic cells
Jaiswal, N., Agrawal, S., & Agrawal, A. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13299 · Cited by 66
Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: Clinical Implications and Treatment
Rahimi, R. S., & Landaverde, C. (2013) · Nutrition in Clinical Practice · doi:10.1177/0884533612470464 · Cited by 61
Yu, Z., Lowndes, J., & Rippe, J. (2013) · Nutrition Research · doi:10.1016/j.nutres.2013.07.020 · Cited by 58
Prather, A. A., Leung, C. W., Adler, N. E., Ritchie, L. D., Laraia, B. A., & Epel, E. S. (2016) · Sleep Health · doi:10.1016/j.sleh.2016.09.007 · Cited by 64
Fructose, Glucocorticoids and Adipose Tissue: Implications for the Metabolic Syndrome
Legeza, B., Marcolongo, P., Gamberucci, A., Varga, V., Bánhegyi, G., Benedetti, A., & Odermatt, A. (2017) · Nutrients · doi:10.3390/nu9050426 · Cited by 66
Nonalcoholic Fatty Liver Disease (NAFLD) and Hepatic Cytochrome P450 (CYP) Enzymes
Jamwal, R., & Barlock, B. J. (2020) · Pharmaceuticals · doi:10.3390/ph13090222 · Cited by 60
Protein Tyrosine Phosphatase 1B Regulates Pyruvate Kinase M2 Tyrosine Phosphorylation
Bettaieb, A., Bakke, J., Nagata, N., Matsuo, K., Xi, Y., Liu, S., AbouBechara, D., Melhem, R., Stanhope, K. L., Cummings, B. P., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.441469 · Cited by 63
Self-citationHigh-sugar diets, type 2 diabetes and Alzheimerʼs disease
Moreira, P. I. (2013) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e328361c7d1 · Cited by 68
Uric Acid and Fructose: Potential Biological Mechanisms
Lanaspa, M. A., Tapia, E., Soto, V., Sautin, Y. Y., & Sánchez‐Lozada, L. G. (2011) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2011.08.006 · Cited by 62
Marek, G. W., Pannu, V., Shanmugham, P., Pancione, B., Mascia, D., Crosson, S. M., Ishimoto, T., & Sautin, Y. Y. (2014) · Diabetes · doi:10.2337/db14-0411 · Cited by 65
Dolan, L. C., Potter, S. M., & Burdock, G. A. (2010) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2010.512990 · Cited by 59
Fructose consumption induces hypomethylation of hepatic mitochondrial DNA in rats
Yamazaki, M., Munetsuna, E., Yamada, H., Ando, Y., Mizuno, G., Murase, Y., Kondo, K., Ishikawa, H., Teradaira, R., Suzuki, K. A. O., et al. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.02.020 · Cited by 63
U.S. obesity as delayed effect of excess sugar
Bentley, R. A., Ruck, D. J., & Fouts, H. N. (2019) · Economics & Human Biology · doi:10.1016/j.ehb.2019.100818 · Cited by 63
Pompili, S., Vetuschi, A., Gaudio, E., Tessitore, A., Capelli, R., Alesse, E., Latella, G., Sferra, R., & Onori, P. (2020) · Nutrition · doi:10.1016/j.nut.2020.110782 · Cited by 56
The Effects of High Fructose Syrup
Moeller, S. M., Fryhofer, S. A., Osbahr, A. J., ROBINOWITZ, C. B., & for the Council on Science and Public Health, A. M. A. (2009) · Journal of the American College of Nutrition · doi:10.1080/07315724.2009.10719794 · Cited by 69
Therapeutic RNA-silencing oligonucleotides in metabolic diseases
Goga, A., & Stoffel, M. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00407-5 · Cited by 58
Both isoforms of ketohexokinase are dispensable for normal growth and development
Diggle, C. P., Shires, M., McRae, C., Crellin, D., Fisher, J., Carr, I., Markham, A. F., Hayward, B. E., Asipu, A., & Bonthron, D. T. (2010) · Physiological Genomics · doi:10.1152/physiolgenomics.00128.2010 · Cited by 60
Gibson, S. A., Gunn, P. J., Wittekind, A., & Cottrell, R. C. (2013) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2012.691574 · Cited by 62
Novel Role of Enteral Monosaccharides in Intestinal Lipoprotein Production in Healthy Humans
Xiao, C., Dash, S., Morgantini, C., & Lewis, G. F. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.300769 · Cited by 56
Evans, R. A., Frese, M., Romero, J., Cunningham, J. H., & Mills, K. (2017) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.145169 · Cited by 61
Tsai, C.-W., Chiu, H.-T., Huang, H.-C., Ting, I., Yeh, H., & Kuo, C. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfx297 · Cited by 61
DeBosch, B. J., Chen, Z., Finck, B. N., Chi, M., & Moley, K. H. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1137 · Cited by 59
Horne, R. G., Yu, Y., Zhang, R., Abdalqadir, N., Rossi, L., Surette, M. G., Sherman, P. M., & Adeli, K. (2020) · Nutrients · doi:10.3390/nu12113557 · Cited by 67
Helsley, R. N., Park, S., Vekaria, H. J., Sullivan, P. G., Conroy, L. R., Sun, R. C., Romero, M. D. M., Herrero, L., Bons, J., King, C. D., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.02.010 · Cited by 61
Lowndes, J., Sinnett, S., Pardo, S., Nguyen, V., Melanson, K., Yu, Z., Lowther, B., & Rippe, J. (2014) · Nutrients · doi:10.3390/nu6031128 · Cited by 58
Fructokinase, Fructans, Intestinal Permeability, and Metabolic Syndrome: An Equine Connection?
Johnson, R. J., Rivard, C. J., Lanaspa, M. A., Otabachian-Smith, S., Ishimoto, T., Cicerchi, C., Cheeke, P. R., McIntosh, B. J., & Hess, T. M. (2012) · Journal of Equine Veterinary Science · doi:10.1016/j.jevs.2012.05.004 · Cited by 63
Kang, I., Espín, J. C., Carr, T. P., Tomás-Barberán, F. A., & Chung, S. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.02.006 · Cited by 60
Advances in Pediatric Nonalcoholic Fatty Liver Disease
Mencin, A., & Lavine, J. E. (2011) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2011.09.005 · Cited by 60
Fukuzawa, T., Fukazawa, M., Ueda, O., Shimada, H., Kito, A., Kakefuda, M., Kawase, Y., Wada, N. A., Goto, C., Fukushima, N., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056681 · Cited by 60
Cummings, B. P., Stanhope, K. L., Graham, J. L., Evans, J. L., Baskin, D. G., Griffen, S. C., & Havel, P. J. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00468.2009 · Cited by 60
Self-citationSangüesa, G., Cascales, M., Griñán‐Ferré, C., Sánchez, R. M., Roglans, N., Pallàs, M., Laguna, J. C., & Alegret, M. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0863-1 · Cited by 66
Yu, Z., Ley, S. H., Sun, Q., Hu, F. B., & Malik, V. S. (2018) · British Journal of Nutrition · doi:10.1017/s0007114517003841 · Cited by 53
Recent origin and evolution of obesity-income correlation across the United States
Bentley, R. A., Ormerod, P., & Ruck, D. J. (2018) · Humanities and Social Sciences Communications · doi:10.1057/s41599-018-0201-x · Cited by 59
Patients With Aldolase B Deficiency Are Characterized by Increased Intrahepatic Triglyceride Content
Simons, N., Debray, F., Schaper, N. C., Kooi, M. E., Feskens, E. J. M., Hollak, C. E. M., Lindeboom, L., Koek, G. H., Bons, J. A. P., Lefeber, D. J., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02795 · Cited by 60
Identification of the fructose transporter GLUT5 (SLC2A5) as a novel target of nuclear receptor LXR
Zwarts, I., van Zutphen, T., Kruit, J. K., Liu, W., Oosterveer, M. H., Verkade, H. J., Uhlenhaut, N. H., & Jonker, J. W. (2019) · Scientific Reports · doi:10.1038/s41598-019-45803-x · Cited by 58
Bremer, A. A., Auinger, P., & Byrd, R. S. (2010) · Journal of Nutrition and Metabolism · doi:10.1155/2010/196476 · Cited by 55
“Although not all studies support an association between SSB consumption and obesity [23, 24], SSB intake has nonetheless been associated with increased body weight, increased fat mass, dyslipidemia, and blood pressure [2, 25–29].”
BackgroundSelf-citationHirahatake, K. M., Meissen, J. K., Fiehn, O., & Adams, S. H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026583 · Cited by 55
“In human subjects fed high fructose diets over 10 weeks, hepatic DNL was increased significantly compared to glucose [4].”
BackgroundFructose during pregnancy affects maternal and fetal leptin signaling
Rodríguez, L., Panadero, M. I., Roglans, N., Otero, P., Álvarez‐Millán, J. J., Laguna, J. C., & Bocos, C. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.02.011 · Cited by 58
Neighborhood and Parental Supports for Physical Activity in Minority Adolescents
Wilson, D. K., Lawman, H. G., Segal, M., & Chappell, S. (2011) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2011.06.037 · Cited by 73
Mellor, K. M., Wendt, I. R., Ritchie, R. H., & Delbridge, L. M. D. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00797.2011 · Cited by 63
Hur, Y., Park, H., Kang, J.-H., Lee, H. A., Song, H. J., Lee, H., & Kim, O.-H. (2015) · Nutrients · doi:10.3390/nu8010020 · Cited by 62
Zhao, L., Guo, X., Wang, O., Zhang, H., Wang, Y., Zhou, F., Liu, J., & Ji, B. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500635 · Cited by 54
Discovery of Fragment-Derived Small Molecules for in Vivo Inhibition of Ketohexokinase (KHK)
Huard, K., Ahn, K., Amor, P. A., Beebe, D. A., Borzilleri, K. A., Chrunyk, B. A., Coffey, S. B., Cong, Y., Conn, E. L., Culp, J. S., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00947 · Cited by 55
Pancreatic cancer: A critical review of dietary risk
Salem, A. A., & Mackenzie, G. G. (2017) · Nutrition Research · doi:10.1016/j.nutres.2017.12.001 · Cited by 57
Şahin, N., Orhan, C., Erten, F., Tuzcu, M., Deeh, P. B. D., Özercan, İ. H., Juturu, V., & Şahin, K. (2019) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22328 · Cited by 55
Pharmacological and non-pharmacological interventions to influence adipose tissue function
Westerink, J., & Visseren, F. L. J. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-13 · Cited by 60
Stenvinkel, P. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu338 · Cited by 58
Yubero‐Serrano, E. M., Delgado‐Casado, N., Delgado‐Lista, J., Pérez‐Martínez, P., Tasset-Cuevas, I., González, M. S., Caballero‐Villarraso, J., García‐Ríos, A., Marín, C., Gutierrez-Mariscal, F. M., et al. (2010) · AGE · doi:10.1007/s11357-010-9199-8 · Cited by 59
Pediatric non-alcoholic fatty liver disease: New insights and future directions
Marzuillo, P., Giudice, E. M. D., & Santoro, N. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v6.i4.217 · Cited by 60
The sugar-sweetened beverage wars: public health and the role of the beverage industry
Welsh, J. A., Lundeen, E. A., & Stein, A. D. (2013) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/01.med.0000432610.96107.f5 · Cited by 55
Ochoa, M., Lallès, J.-P., Malbert, C.-H., & Val-Laillet, D. (2015) · European Journal of Nutrition · doi:10.1007/s00394-014-0776-y · Cited by 52
Atherogenic postprandial remnant lipoproteins; VLDL remnants as a causal factor in atherosclerosis
Nakajima, K., & Tanaka, A. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.12.039 · Cited by 57
Self-citationVasopressin mediates fructose-induced metabolic syndrome by activating the V1b receptor
Andres-Hernando, A., Jensen, T. J., Kuwabara, M., Orlicky, D. J., Cicerchi, C., Li, N., Roncal-Jimenez, C. A., Garcia, G. E., Ishimoto, T., Maclean, P. S., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.140848 · Cited by 56
What is the appropriate upper limit for added sugars consumption?
Rippe, J. M., Sievenpiper, J. L., Lê, K., White, J. S., Clemens, R., & Angelopoulos, T. J. (2016) · Nutrition Reviews · doi:10.1093/nutrit/nuw046 · Cited by 61
Calories from Soft Drinks — Do They Matter?
Caprio, S. (2012) · New England Journal of Medicine · doi:10.1056/nejme1209884 · Cited by 53
Güney, C., Bal, N. B., & Akar, F. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e18896 · Cited by 60
Peñalvo, J. L., Oliva, B., Sotos‐Prieto, M., Uzhova, I., Moreno‐Franco, B., León-Latre, M., & Ordovás, J. M. (2015) · Revista Española de Cardiología · doi:10.1016/j.recesp.2014.09.018 · Cited by 54
FRUCTOSE INDUCES GLUCONEOGENESIS AND LIPOGENESIS THROUGH A SIRT1-DEPENDENT MECHANISM
Caton, P., Nayuni, N. K., Khan, N., Wood, E. G., & Corder, R. (2011) · Journal of Endocrinology · doi:10.1530/joe-10-0190 · Cited by 63
Bremer, A. A., Stanhope, K. L., Graham, J. L., Cummings, B. P., Ampah, S. B., Saville, B. R., & Havel, P. J. (2013) · Journal of Nutrition · doi:10.3945/jn.113.178061 · Cited by 56
Self-citationEnergy compensation following consumption of sugar-reduced products: a randomized controlled trial
Markey, O., Jeune, J. L., & Lovegrove, J. A. (2015) · European Journal of Nutrition · doi:10.1007/s00394-015-1028-5 · Cited by 57
Bruun, J. M., Maersk, M., Belza, A., Astrup, A. V., & Richelsen, B. (2015) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2015.95 · Cited by 52
Improving dietary patterns in patients with nonalcoholic fatty liver disease
Carvalhana, S., Machado, M. V., & Cortez-Pinto, H. (2012) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e3283566614 · Cited by 51
Li, J., Wang, W., Fan, C., Wang, M., Zhang, X., Hu, Q.-H., & Kong, L. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/303902 · Cited by 73
RetractedFructose vs. glucose and metabolism: do the metabolic differences matter?
Sievenpiper, J. L., de Souza, R. J., Cozma, A. I., Chiavaroli, L., Ha, V., & Mirrahimi, A. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000042 · Cited by 50
Lana, A., Rodríguez‐Artalejo, F., & López‐García, E. (2014) · Journal of Nutrition · doi:10.3945/jn.114.195230 · Cited by 61
An accelerated mouse model for atherosclerosis and adipose tissue inflammation
Neuhofer, A., Wernly, B., Leitner, L., Sarabi, A., Sommer, N. G., Staffler, G., Zeyda, M., & Stulnig, T. M. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-23 · Cited by 62
Nigro, D., Menotti, F., Cento, A. S., Serpe, L., Chiazza, F., Bello, F. D., Romaniello, F., Medana, C., Collino, M., Aragno, M., et al. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.01.010 · Cited by 55
Laing, B. B., Lim, A. G., & Ferguson, L. R. (2019) · Nutrients · doi:10.3390/nu11071532 · Cited by 58
The Role of Fructose as a Cardiovascular Risk Factor: An Update
Busnatu, Ș., Salmen, T., Pană, M.-A., Rizzo, M., Stallone, T., Παπάνας, Ν., Popovic, D. S., Tănăsescu, D., Şerban, D., & Stoian, A. P. (2022) · Metabolites · doi:10.3390/metabo12010067 · Cited by 57
Wang, J. W., Mark, S., Henderson, M., O'Loughlin, J., Tremblay, A., Wortman, J., Paradis, G., & Gray‐Donald, K. (2013) · Pediatric Obesity · doi:10.1111/j.2047-6310.2012.00108.x · Cited by 51
“To our knowledge, there are only two studies that suggest that fructose intake does not influence the risk of developing hypertension, but the data are from self-reported hypertension (23,52).”
BackgroundResult
Metadata
- Authors
- Stanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C., Bremer, A. A., Graham, J. L., Hatcher, B., Cox, C. L., Dyachenko, A., Zhang, W., McGahan, J. P., Seibert, A., Krauss, R. M., Chiu, S., Schaefer, E. J., Ai, M., Otokozawa, S., Nakajima, K., Nakano, T., Beysen, C., Hellerstein, M. K., Berglund, L., & Havel, P. J.
- Affiliations
- University of California, Davis (US)
- University of California, San Francisco (US)
- United States Department of Agriculture (US)
- Touro University California (US)
- UCSF Benioff Children's Hospital (US)
- Tufts University (US)
- KineMed (United States) (US)
- VA Northern California Health Care System (US)
- Corresponding author
- Havel, Peter J.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2009-05-01
- Volume
- 119
- Issue
- 5
- Pages
- 1322-1334
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC2673878
- OpenAlex
- W2146966453
- Cited by
- 1,765
- References
- 86
- Citations by year
- 2026: 56 · 2025: 73 · 2024: 56 · 2023: 96 · 2022: 92 · 2021: 101 · 2020: 113 · 2019: 112 · 2018: 135 · 2017: 105 · 2016: 118 · 2015: 121 · 2014: 135 · 2013: 143 · 2012: 108
- FWCI
- 74.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- American Diabetes Association (UL1 RR024146)
- U.S. Department of Agriculture (5306‐51530‐016‐00D, UL1 RR024146)
- Bristol-Myers Squibb
- Pfizer
- Sanofi
- American College of Radiology Imaging Network
- School of Veterinary Medicine, University of California, Davis
- KineMed
- Novo Nordisk
- Otsuka Pharmaceutical
- National Institutes of Health (AT‐003545, 5r01hl075675-05, 5r01hl091333-02, HL‐091333, R01 HL-075675, HL‐075675, RR024146)
- University of California, Davis (95616, RR024146, UL1 RR024146)
- Agricultural Research Service (5306‐51530‐016‐00D)
- National Heart, Lung, and Blood Institute (R01 HL-075675, R01 HL-091333, HL-091333, R01HL107256)
- National Center for Research Resources (RR-024146, 5306-51530-016-00D, UL1RR024146)
- National Center for Complementary and Integrative Health (AT0-02993, AT0-03545, AT 002599, R21AT002993, R21AT002599)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- dietary fructose, glucose, visceral fat, insulin resistance, insulin sensitivity, dyslipidemia, hepatic de novo lipogenesis, triglycerides, lipoprotein remodeling, oxidized LDL, remnant-like particles, overweight and obesity, weight gain
- MeSH terms
- Beverages, Blood Glucose, Body Weight, Energy Intake, Double-Blind Method, Eating, Female, Fructose, Glucose, Humans, Insulin, Insulin Resistance, Lipids, Lipoproteins, Liver, Male, Middle Aged, Models, Biological, Obesity, Sex Characteristics, Triglycerides, Gene Expression, Dietary Sucrose, Subcutaneous Fat, Intra-Abdominal Fat, Overweight, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.